Drug Trial Radar · NCT07941479
Study of the Effects of Rimonabant on Functional Recovery in Subacute Stroke Patients
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Nov 30, 2026
Primary completion
Jan 31, 2028
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- Sinfatin S.LIndustry
- Sponsor type
- Industry
- First posted
- Nov 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main goal of this clinical trial is to assess the effect of rimonabantim on the functional independence in adults who have recently experienced a stroke. The study will enroll 80 participants aged 18 to 75 years who had an stroke 30 to 90 days before enrolment and who have difficulties performing daily activities. Participants will receive either rimonabant (5 mg) or placebo (a look-alike tablet that contains no drug) once daily for 90 days. Neither the participants nor the investigators will know which treatment is being given.The study will also help to learn about the safety of rimonabant.
Conditions
- Subacute Stroke
Interventions
RimonabantDrug
Rimonabant 5 mg administered orally as one orally disintegrating tablet (ODT) once daily for 90 consecutive days.
PlaceboDrug
Participants will receive one matching placebo orally disintegrating tablet (ODT) once daily for 90 consecutive days. The placebo contains no rimonabant.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Barthel Index (BI)Time frame: Baseline and end of follow-up (day 135)
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Hospital Universitario de Albacete
Albacete, Albacete, Spain
Institut Guttmann
Badalona, Barcelona, Spain
Jiménez Lucena S.L. (CLÍNICA I+TÚ)
Córdoba, Córdoba, Spain
Hospital Los Madroños
Brunete, Madrid, Spain
Hospital Clínico San Carlos (HCSC)
Madrid, Madrid, Spain
Hospital Universitario La Paz
Madrid, Madrid, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.